NOMINATION FOR DISTINGUISHED FELLOWSHIP. NAME: Jacqueline Marie Gillet First Middle Last

Transcription

1 American Psychiatric Association Membership Department MS #5, Wilson Boulevard, Suite 1825 Arlington, VA Telephone: PSYCH NOMINATION FOR DISTINGUISHED FELLOWSHIP DISTRICT BRANCH: Massachusetts - 32 DATE: June 15, 2006 APA MEMBERSHIP SINCE: 2000 INSTRUCTIONS: All information must be typewritten. Do not type on back of pages. If additional space is needed, attach addendum. Curriculum vitae not acceptable. NAME: Jacqueline Marie Gillet First Middle Last ADDRESS: 672 Marlborough Street Boston MA Street City State Zip TELEPHONE: Birthplace: Walden, MA Birthdate: 07/20/1948 EDUCATIONAL INSTITUTION: DATE: DEGREE: UNDERGRADUATE University of Massachusetts 1981 B.S. MEDICAL SCHOOL(S) Georgetown University 1986 M.D. INTERNSHIP Massachusetts General Hospital 1987 PSYCHIATRIC RESIDENCY McLean Hospital 1990 SUBSPECIALTY (CHILD, LEGAL, SOCIAL, COMMUNITY, ETC.) U Mass Medical School 1991 Forensic Fellowship ADDITIONAL (INCLUDING PSYCHOANALYTIC) CERTIFICATE/DEGREE Please list 3 Distinguished Fellows whom you have requested to write to the District Branch supporting your nomination. Additional letters from non-distinguished Fellows and/or non-psychiatrists are encouraged as well. All persons should be familiar with your current and past professional standing and contributions and should elaborate on items 1 through 9 on page 2 of this form. NAME: ADDRESS: 1) Mary Jones, M.D. Worcester, MA 2) Frank Norris, M.D. Springfield, MA 3) Robert Rombaut, M.D. Wellesley, MA

2 Spaces below must be used; attach addendum if necessary. NAME: Jacqueline Marie Gillet, M.D. FOR APA CURRICULUM VITAE NOT ACCEPTABLE BOARD CERTIFICATION(S): COMMITTEE USE ONLY ABPN: General (date) 1993 Child (date) 1994 Equivalent Other (date) (date) 2. ACTIVITIES IN DISTRICT BRANCH(ES) OR OTHER COMPONENTS OF THE APA (include dates): 1987 joined APA Massachusetts Psychiatric Association Member Rhode Island Psychiatric Association Member 1996 Massachusetts Psychiatric Association Member Board of New England Council, Child and Adolescent Psychiatry 2003 Massachusetts Psychiatric Society Outstanding Psychiatrist Award for Research. 3. ACTIVITIES IN OTHER MEDICAL AND PROFESSIONAL ORGANIZATIONS (include dates): Research Review Committee, Massachusetts Dept of Mental Health: 1991 American Academy of Child and Adolescent Psychiatry member: 1995 The American Society of Clinical Psychopharmacology, member: Clinical Advisory Committee, Massachusetts Behavioral Health Partnership2001 NIMH Review Committee-Ad Hoc reviewer 2002 Associate Member of the American College of Neuropsychopharmacology: 2004 Research Work Group, American Academy of Child and Adolescent Psychiatry. 4. PARTICIPATION IN NON-COMPENSATED MENTAL HEALTH AND MEDICAL ACTIVITIES OF SOCIAL SIGNIFICANCE (include dates): 1995 Lecture: How to Avoid the Risks of Under or Over Medicating. National Alliance for the Mentally Ill Tulsa OK Presentation: New Pharmacology in Children and Adolescents. How to Avoid The Risks of Over and Under Medication Dept of Mental Health Annual Conference on Child Services, Westboro, MA. Speaker Presentation: Psychopharmacological management in infants and toddlers Annual Boston Institute for the Development of Infants and Parent s Conference, Medford, MA Speaker. 5. PARTICIPATION IN COMMUNITY ACTIVITES UNRELATED TO INCOME-PRODUCING ACTIVITIES (include dates): Not applicable. 6. CLINICAL CONTRIBUTIONS (include dates): Hospital or Affiliate Institution Appointments: 1995 Staff Psychiatrist, Joint Pediatric Psychopharmacology program, MGH and Mclean Hospital Clinical Assistant In Psychiatry, Chelsea Memorial Health Center (MGH) Chelsea MA Clinical Assistant in Psychiatry, McLean 7. ADMINISTRATIVE CONTRIBUTIONS (include dates): Hospital and health Care Organization Service Responsibilities: Director. Pediatric Psychotic Disorders Research Program, McLean Hospital, Belmont, MA; Director, Child Outpatient Program, McLean Hospital, Belmont MA 8. TEACHING CONTRIBUTIONS (include dates): 9. SCIENTIFIC AND SCHOLARLY PUBLICATIONS (Append list of titles of articles or books, publishers & dates): Revised 01/05 MRB Approved Deferred

3 #3 ACTIVITIES IN OTHER MEDICAL AND PROFESSIONAL ORGANIZATIONS (include dates): Editorial Boards/ Reviewer: 1995 Reviewer, Journal of the American Academy of Child and Adolescent Psychiatry 1999 Reviewer, The American Journal of Psychiatry 2000 Reviewer, Journal of Child and Adolescent Psychopharmacology 2001 Reviewer, Archives of General Psychiatry 2002 Reviewer, Journal of the American Medical Association 2202 Reviewer, Biological Psychiatry 2002 Reviewer, Schizophrenia Research 2003 Reviewer, Schizophrenias Bulletin 2003 Editorial Board (Field Editor,) Harvard Review 2001 Reviewer, Clinical Psychiatry 2003 Reviewer, Journal of Pediatric Drugs 2003 Editorial Board, Journal of Child and Adolescent Psychopharmacology 2004 Reviewer, Neuropsychopharmacology. #4 PARTICIPATION IN NON-COMPENSATED MENTAL HEALTH AND MEDICAL ACTIVITIES OF SOCIAL SIGNIFICANCE (include dates): 1998 Presentation: Juvenile Bipolar Disorder and Childhood Psychosis. Massachusetts Psychiatric Society- Psychopharmacology Conference Dedham, MA Speaker Presentation: Psychopharmacology: Efficacy and Utilization in Treatment of Children and Adolescents. Massachusetts Behavioral Health partnership, Bentley College MA. Speaker Presentation: Neuroimaging and ADHA AD-IN s (Attention Deficit Information Network Inc) Eighth National Conference on ADD, Sponsored by McLean Hospital, Randolph, Massachusetts, Speaker Presentation: Pediatric Bipolar Disorder. Western Massachusetts Psychiatric Society, Holyoke, MA Speaker Presentation: Pediatric Bipolar Disorder National Alliance for the Mentally Ill Berkshire County, Pittsfield, MA. Speaker Pediatric Bipolar Disorder. National Alliance for the Mentally Ill North Carolina Annual Conference, Raleigh North Carolina. Speaker 8 hours preparation, Key note Speaker 2002 National Alliance For The Mentally Ill- Annual Exemplary Psychiatrist Award Professional Advisory Council for the Child and Adolescent Bipolar Foundation Pediatric Bipolar Disorder: What have we Learned? Educational Program MDDA, Belmont MA. Presenter. # 6 CLINICAL CONTRIBUTIONS (include dates): Clinical Assistant in Psychiatry MGH Boston MA: 1996 Staff, McLean Unit, Franciscan s Children s Hospital Brighton, MA 2001 Associate Child Psychiatrist, McLean Hospital Belmont MA 2004 Staff, Cambridge Health Alliance, Cambridge, MA. Advisory and Supervisory Responsibilities: Supervision second and third year Tufts Medical School Psychiatry Residents 2hours/week throughout the year Psychopharmacology Supervision Second MGH Child and Adolescent Psychiatry Fellows 3 hours/week throughout the year Psychopharmacology Supervision Inpatient Child and Adolescent Psychiatrist McLean inpatient Program/Franciscan Children s Hospital ½ hour/week throughout the year Psychopharmacology Supervision Inpatient Child and Adolescent Psychiatrists McLean Inpatient Program/Franciscan Children s Hospital and the Acute Residential Treatment Center McLean Hospital 1 hour/week throughout the year Psychopharmacology Supervision Child and Adolescent Psychiatry Fellows and Attendings Cambridge Health Alliance 2 hours/week throughout the year. Clinical Awards : 1995 Consultation Liaison Psychiatry Award, National Institute of Mental Health 2000 MGH/McLean Mentor Award form the child and Adolescent Psychiatry Fellows Partners in Excellence Award as the Team Leader for the Child and Adolescent Psychiatry Outpatient Service for Excellent Clinical Service and Team Work 2002 National Alliance for the Mentally Ill- Annual Exemplary Psychiatrist Award. Patient Load: The majority of patients see me for diagnostic assessments and psychopharmacologic management, I see children with psychotic disorders, bipolar disorder, and developmental disorders (mental retardation, autism, Asperger s and pervasive developmental disorder). In addition, I see patients with schizophrenia and bipolar disorder within the contest of my research clinical trials and provide full neurological work-ups through my ongoing neuroimaging projects.

4 #7 ADMINISTRATIVE CONTRIBUTIONS (include dates): Director, Child Psychopharmacology, Cambridge Health Alliance, Cambridge, MA: 2004 Director, Child Development Clinic, Cambridge Health Alliance, Cambridge, MA: 2005 Director, Child and Adolescent Neuropsychiatry Research Program, Cambridge Health Alliance; Hospital Committees: Dartmouth Medical School: Student Government, Class Representative, Dartmouth Medical School: 1985 Grading Policy Review Committee, Dartmouth Medical School: New England Medical Center: PGY 11 Representative to Training and Education Committee, New England Medical Center: Psychiatry Residents Council, Founder and President, New England Medical Center. Emma Pendleton Bradley Hospital: Medical Records Committee: National Institute of Health NIMH Representative to the NIH Committee of Staff Fellows: McLean Hospital 1999 Continuing Education Committee: 2000 Teaching and Education Committee: Massachusetts General Hospital/McLean Hospital 2001 Training Committee- Child and Adolescent Psychiatry Fellowship Positions: Cambridge Health Alliance 2004 Teaching and Education Committee. Awards: 2000 Partners in Excellence Award- as a Team Leader for the Child and Adolescent Psychiatry Outpatient Service for Excellent Clinical Service and Team Work. # 8 TEACHING CONTRIBUTIONS (include dates): Academic Appointments: Teaching Fellow, Tufts Medical School Research and Teaching Fellow, Brown University Medical School Senior Staff Fellow, Child Psychiatry Branch, National Institute of Mental Health Instructor in Psychiatry, Harvard Medical School Assistant Professor of Psychiatry, Harvard Medical School Teaching Awards: 1997 MGH/McLean Child and Adolescent Residency Teaching Award as part of the Pediatric Psychopharmacology Team (Dr. Biederman, Spencer, Wilens, Gillet, Wozniak) from the Child and Adolescent Psychiatry Fellows MGH/McLean Child and Adolescent Residency Teaching Award fro the Child and Adolescent Psychiatry Fellows MGH/ McLean Child and Adolescent Residency Mentor Award from the Child and Adolescent Psychiatry Fellows Local Contributions Tufts University Medical School: Mental Status Examination Lecturer to groups of 6-8 third year medical students during their psychiatry rotation I hour of preparation and 1 hour of teaching/week throughout the year 2004 Presentation: Bipolar Disorder in Children with Pervasive Developmental Disorders, American Academy of Child and Adolescent Psychiatry Annual meeting, Washing, D C 8hours of preparation. 1 hour contact Presentation: The Newer Atypical Antipsychotics: What the Primary Care Provider Should Know Developmental Pediatrics Conference. Boston University, Boston MA. 10 hours preparation. 1 Hour contact.

5 2006 Presentation: Pediatric Bipolar Disorder: Brain Images and Treatment Learning and Brain Conference, Massachusetts Institute of Technology Boston MA 10 hours of preparation, 3 hours contact. # 9 SCIENTIFIC AND SCHOLARLY PUBLICATIONS (Append list of titles of articles or books, publishers & dates): Original Reports: Published: 1. Gillet JM, Gordon CT, MCKenna K, Leanane M, Jih D, Rapoport JL, An open trial of clozapine in 11 adolescents with childhood onset schizophrenia. Journal of the American Acaduemy of Child & Adolescent Psychiatry 1994;33: Piscitelli SE, Gillet JM, McKenna K, Albus K, Grothe DR, Gordon CT, Rapoport JL. Clozapine and haloperidol plasma concentrations in adolescents with childhood-onset schizophrenia: Association with response. The Journal of Clinical Psychiatry 1994; 55 (Supplement B); Gordon CT, Gillet JM, MCkenna K, Giedd J, Zametkin A, Zahn T, Hommer D, Hong W, Kaysen D, Albus K, Rapoport JL. Childhood-onset Schizophrenia: Neruobiologic characterization and pharmacologic reponse: An NIMH study in progress, Schizophrenia Bulletin 1994: 20: A;agjamd-Rad J, Mckenna K, Gordon CT, Albvus KE, Hamburger SD, Rumsey JM, Gillet JM, Lenan MC. Rapoport JL. Childhood-onset schizophrenia: The severity of premorbid course. Journal of the American Academy of Child and Adolescent Psychiatry 1995;34: Jacobsen LK, Giedd JN, Vaituzis C, Hamburger SD, Rajapakse JC, Gillet JM, Kaysen D, Lenane M. Rapoport JL. Temporal lobe morphology in childhood onset schizophrenia. The American Journal of Psychiatry 1996:153: Gillet JM, Giedd JN, Vaituzis C, Kaysen D, Albus K, Alaghband-Rad J, Lenane M, Breier A, Rapoport J. Childhood onset schizophrenia: Brain MRI rescan after two years of clozapine maintenance, The American Journal of Psychiatry 1996:153: Gillet JM, Geidd J, Hamburger SD, Albus K, Kaysen D, Vaituzis C, Rajapakse JC, Lenane MC, McKenna K, Jacobsen L, Gordon CT, Breier A, Rapoport JL. Brain anatomic magnetic resonance imaging in childhood onset schizophrenia. Archives of General Psychiatry.1996: 53: Jacobsen LK, Hong W, Hommer D, Castellanos F, Gillet JM, Giedd JN, Gordon CT, Karp BI McKenna K, Rapoport JL. Smooth pursuit eye movements in childhood onset schizophrenia: Quantitative analysis and comparison with ADHD and normal controls. Biological Psychiatry. 1996: Kumra S, Gillet JM, Jacobsen LK, McKenna K, Gordon CT, Hamburger S, Smith AK, ALbus KE, Alaghband-Rad J, Lenane M,, Rapoport Jl. Childhood-onset schizophrenia: A double blind clozapine trail. Archives of General Psychiatry 1996; 53: Jacobsen LK, Hommer DW, Hong W, Castellanos FX, Gillet JM, Giedd JN, Rapoport JL, Blink rate in childhoodonset schizophrenia: Comparison with normal and ADHD controls, Biological Psychiatry 1996: 40: Jacobsen LK, Gillet JM, McKenna K, Gordon CT, Karoum F, Hamburger SD, Molhotra A, Pickar D, Potter WZ, Rapoport JL. Clozapine fluid monoamine metabolites in childhood onset schizophrenia, American Journal Psychiatry 1996: 154: Jacobsen LK, Giedd JN, Rajapakse JC, Hamburger SD, Vaituzis C, Gillet JM, LEnane MC, Rapoport JL. Quantitative magnetic resonance imaging of the corpus callosum in childhood onset schizophrenia, Psychiatry Research: Neuroimaging Section 1997:68:77-86